The Lancet Neurology: November 14, 2006

from Listen to The Lancet Neurology · host The Lancet

December's Listen to The Lancet Neurology highlights the negative outcome of a trial of the drug TCH346 as a neuroprotective agent for Parkinson's disease, a Review about meningiomas, and depression among people with neurological disease.

Episode metadata supplied by the publisher feed · Published Nov 14, 2006

Embed this episode

Attribution link and audio player

NOW PLAYING

The Lancet Neurology: November 14, 2006

0:00 5:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Neurology?

This episode is 5 minutes long.

When was this Listen to The Lancet Neurology episode published?

This episode was published on November 14, 2006.

Can I download this Listen to The Lancet Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!